Detalhe da pesquisa
1.
Milvexian for the Prevention of Venous Thromboembolism.
N Engl J Med
; 385(23): 2161-2172, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780683
2.
Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.
Stroke
; 54(3): e75-e85, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848427
3.
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial.
Circulation
; 141(1): 10-20, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747786
4.
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.
N Engl J Med
; 377(5): 431-441, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28693366
5.
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Am Heart J
; 226: 85-93, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526533
6.
Temporal trends in pharmacologic prophylaxis for venous thromboembolism after hip and knee replacement in older adults.
Vasc Med
; 25(5): 450-459, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516054
7.
The importance of adherence and persistence in the elderly atrial fibrillation patient.
Eur Heart J Suppl
; 22(Suppl I): I38-I42, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33088233
8.
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Circulation
; 138(16): 1666-1676, 2018 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29871978
9.
Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
Circulation
; 138(9): 889-897, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29678813
10.
Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.
Am Heart J
; 211: 77-89, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901602
11.
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial.
Am Heart J
; 208: 123-131, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30579505
12.
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin.
J Thromb Thrombolysis
; 48(1): 27-34, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972712
13.
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.
J Thromb Thrombolysis
; 47(3): 345-352, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30790160
14.
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
Eur Heart J
; 39(6): 477-485, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29069359
15.
Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
Circulation
; 146(12): 958-960, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36121911
16.
Idarucizumab for Dabigatran Reversal.
N Engl J Med
; 373(6): 511-20, 2015 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26095746
17.
Anticoagulation reversal in vitamin K antagonist-associated intracerebral hemorrhage: a systematic review.
J Thromb Thrombolysis
; 46(2): 227-237, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29687299
18.
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
J Thromb Thrombolysis
; 46(4): 435-439, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30051164
19.
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
Eur Heart J
; 38(12): 852-859, 2017 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26848149
20.
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
Eur Heart J
; 38(12): 860-868, 2017 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26848150